Skip to Content
Morningstar

Illumina Inc ILMN

Morningstar Rating
Unlock
Stock XNAS Rating as of
$122.87 −1.59 (1.28%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

New Management Team Is Trying to Turn Illumina's Story Around

Julie Utterback

Illumina aims to transform human health practices through its leadership of genomic sequencing and related applications. The firm provides a broad range of instruments and related consumables to help researchers and clinicians identify and understand genetic variations. The scale of these projects can be wide, such as population genomic initiatives being pursued in many countries, or narrow, such as noninvasive prenatal screening. We believe Illumina will continue to benefit from the rapidly expanding applications of genomic sequencing tools through its own innovation and select acquisitions.

Read Full Report

Price vs Fair Value

View History
ILMN is trading at a 45% discount.
Price
$124.46
Fair Value
$592.00
Uncertainty
High
1-Star Price
$157.50
5-Star Price
$989.90
Economic Moat
Wrkjzh
Capital Allocation
Xwylvcwmr

Bulls Say, Bears Say

Bulls

Genomic sequencing remains a relatively early stage market, and expanding sequencing indications, including the nascent liquid biopsy applications that would use its sequencers, create large growth opportunities for Illumina with or without Grail.

Bears

Disruptive technology risks could threaten Illumina's industry-leading sequencing platform, leading to market share losses and profit declines.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ILMN is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$124.46
Day Range
$120.82–124.74
52-Week Range
$89.00–228.13
Bid/Ask
$123.04 / $124.00
Market Cap
$19.57 Bil
Volume/Avg
1.3 Mil / 1.7 Mil

Key Statistics

Price/Earnings (Normalized)
141.23
Price/Sales
4.31
Dividend Yield (Trailing)
—
Dividend Yield (Forward)
—
Total Yield
—

Company Profile

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina’s high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Mid Growth
Total Number of Employees
9,300
Website
https://www.illumina.com

Competitors

Valuation

View More
Metric
ILMN
GH
EXAS
Price/Earnings (Normalized)
 141.23——
Price/Book Value
 3.4012.333.65
Price/Sales
 4.313.204.56
Price/Cash Flow
 34.18—72.81
Price/Earnings
ILMN
GH
EXAS

Financial Strength

Metric
ILMN
GH
EXAS
Quick Ratio
 1.146.111.91
Current Ratio
 1.666.542.32
Interest Coverage
 −14.26−198.43−7.26
Quick Ratio
ILMN
GH
EXAS

Profitability

Metric
ILMN
GH
EXAS
Return on Assets (Normalized)
 0.03%−20.62%−0.51%
Return on Equity (Normalized)
 0.06%−253.35%−1.05%
Return on Invested Capital (Normalized)
 0.21%−25.20%−0.23%
Return on Assets
ILMN
GH
EXAS
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Diagnostics & Research Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncNgrvpvgxwRckt$209.3 Bil
DHR
Danaher CorpDvkwmwrjpKmmmkgc$185.5 Bil
IQV
IQVIA Holdings IncMgmdlkrgxYnttr$43.4 Bil
IDXX
IDEXX Laboratories IncRhqtkvfcdbKgpbkp$41.0 Bil
A
Agilent Technologies IncGkzzcznsrYshl$40.3 Bil
MTD
Mettler-Toledo International IncWnmslytjzKppbttf$26.4 Bil
ICLR
Icon PLCDbtjvnfxGgbvpb$25.2 Bil
WAT
Waters CorpYlcghtnlbTqyx$18.0 Bil
LH
Laboratory Corp of America HoldingsSlctlfcmkrDktkvxt$17.5 Bil

Sponsor Center